These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8495491)
1. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules. Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491 [TBL] [Abstract][Full Text] [Related]
2. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell. Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420 [TBL] [Abstract][Full Text] [Related]
3. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807 [TBL] [Abstract][Full Text] [Related]
4. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. Brooks AG; McCluskey J J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726 [TBL] [Abstract][Full Text] [Related]
5. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143 [TBL] [Abstract][Full Text] [Related]
6. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation. Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876 [TBL] [Abstract][Full Text] [Related]
7. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells. Sponaas A; Carstens C; Koch N Gene Ther; 1999 Nov; 6(11):1826-34. PubMed ID: 10602378 [TBL] [Abstract][Full Text] [Related]
8. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914 [TBL] [Abstract][Full Text] [Related]
9. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells. Bertolino P; Forquet F; Pont S; Koch N; Gerlier D; Rabourdin-Combe C Int Immunol; 1991 May; 3(5):435-43. PubMed ID: 1655000 [TBL] [Abstract][Full Text] [Related]
10. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. Snider DP; Segal DM J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743 [TBL] [Abstract][Full Text] [Related]
11. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011 [TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331 [TBL] [Abstract][Full Text] [Related]
13. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. Dang LH; Lien LL; Benacerraf B; Rock KL J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833 [TBL] [Abstract][Full Text] [Related]
14. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524 [TBL] [Abstract][Full Text] [Related]
15. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Svensson M; Pfeifer J; Stockinger B; Wick MJ Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741 [TBL] [Abstract][Full Text] [Related]
16. High efficiency of endogenous antigen presentation by MHC class II molecules. Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977 [TBL] [Abstract][Full Text] [Related]
17. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Peterson M; Miller J Nature; 1992 Jun; 357(6379):596-8. PubMed ID: 1608470 [TBL] [Abstract][Full Text] [Related]
18. Invariant chain alters the malignant phenotype of MHC class II+ tumor cells. Clements VK; Baskar S; Armstrong TD; Ostrand-Rosenberg S J Immunol; 1992 Oct; 149(7):2391-6. PubMed ID: 1527384 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells. Adorini L; Ullrich SJ; Appella E; Fuchs S Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863 [TBL] [Abstract][Full Text] [Related]
20. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. Bikoff EK J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]